Epigenetic pathways and plasticity in brain tumors

Area of Science:

• Neuro-oncology
• Cancer Biology
• Epigenetics

Background:

• Primary brain tumors, including glioblastoma (GBM), medulloblastoma (MB), and diffuse intrinsic pontine glioma (DIPG), present significant treatment challenges.
• Blood-brain barrier (BBB) penetration and tumor cell heterogeneity limit the efficacy of current therapeutic compounds.
• Brain tumor cell-of-origin plasticity and differentiation contribute to treatment resistance and tumor recurrence.

Purpose of the Study:

• To review active epigenetic pathways in GBM, MB, and DIPG.
• To identify common epigenetic targets across these primary brain tumors using single-cell RNA sequencing data.
• To explore combination therapies for brain tumors based on multi-omics approaches.

Main Methods:

• Literature review of epigenetic pathways in primary brain tumors.
• Comparative analysis of single-cell RNA sequencing data from GBM, MB, and DIPG.
• Discussion of potential multi-omics-based combination therapies.

Main Results:

• Identified active epigenetic pathways in GBM, MB, and DIPG.
• Highlighted common epigenetic vulnerabilities across different primary brain tumor types.
• Proposed generalizable combination therapy strategies.

Conclusions:

• Epigenetic targeting combined with standard treatments may overcome cancer cell plasticity.
• Multi-omics approaches can inform the development of novel, combination therapies for brain tumors.
• Understanding epigenetics, plasticity, and heterogeneity is crucial for advancing brain tumor treatment.